Government has apparently dropped ‘gateway’ theory marijuana critics…

Government has apparently dropped ‘gateway’ theory, marijuana critics should too. Recently the Drug Enforcement Administration (DEA) quietly removed a report from its website, suggesting that it is finally giving up the false theories that cannabis is a “gateway drug,” or that it causes permanent brain damage or psychosis.

http://thehill.com/blogs/pundits-blog/the-administration/319996-federal-gov-apparently-dropped-gateway-drug-theory

Durban – TALKING SOLUTIONS ON DRUGS – Tuesday, 28 February 2017 at the DUT Steve Biko Campus

As the whoonga (nyaope) “bluetooth” drug craze continues to send shock-waves throughout South Africa, the Urban Futures Centre (UFC) at the Durban University of Technology (DUT), in partnership with the TB/HIV Care Association (THCA), are preparing to host the Let’s talk about drug solutions, and stop the harm! seminar, which focuses on problematic drug use and solutions which seek to reduce harm. The seminar will be held on Tuesday, 28 February 2017 at the DUT Steve Biko Campus, Block S2, Level 1, Room 104 (18h00 to 20h00).

A Canadian company trading under the ticker WEED…

A Canadian company trading under the ticker WEED is valued at $1 billion. Marijuana is transforming into the darling of daring investors, and the nascent legal weed industry is excited about the prospects for profits.

https://qz.com/915986/canopy-growth-weed-valued-at-1-billion/

[STUDY] Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)

The coauthors of this study note that Cannabis is widely used as a self-management strategy by patients with a wide range of symptoms and diseases including chronic noncancer pain, but the safety of cannabis use for medical purposes has not been systematically evaluated. The Journal of Pain Open Access paper, entitled “Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)“ (The Journal of Pain, 2015; DOI: http://dx.doi.org/10.1016/j.jpain.2015.07.014), is coauthored by Mark A. Ware, MBBS MRCP MS, Tongtong Wang, BMed PhD, Stan Shapiro, PhD, Jean-Paul Collet, MD PhD, Aline Boulanger, MD, John M. Esdaile, MD, Allan Gordon, MD, Mary Lynch, MD, Dwight E. Moulin, MD, and Colleen OConnell, MD.

Do you want to email the MCC about medical cannabis cultivation licenses in South Africa?

The below response was received with regards to a medicinal cannabis cultivation license in South Africa inquiry made to the Medicines Control Council (MCC) via a cannabis activist: “Thank you for this enquiry. Kindly be informed that the Medicines Control Council (MCC) is currently developing a framework for growing medical cannabis that will soon go out for public comment. In addition the amendment Act to the Medicines and Related Substances Act, (Act 14 of 2015) will soon be promulgated to create the legal framework for the MCC to issue a license to manufacturers of Scheduled substances and thus for growing medical cannabis.

Floridians can now apply for medical marijuana ID cards

The state of Florida has started to issue medical marijuana identification cards for patients and caregivers. The Florida Department of Health’s Office of Compassionate Use started the process Thursday by drafting applications and accepting completed applications for review.

http://wsvn.com/news/local/floridians-can-now-apply-for-medical-marijuana-id-cards

Unbanning dagga products could improve medical research, says MCC

The debate surrounding the medicinal use of marijuana (dagga) continues as plans to recognise it as a prescription drug move forward.
The use of dagga for prescribed medication will potentially be legalised in South Africa this month.
The Medical Control Council (MCC) says it will soon publish proposed guidelines on dagga production for medicinal use. Dagga is said to help with pain management for people living with cancer, glaucoma, epilepsy and multiple sclerosis (MS). MCC chairperson Prof Helen Rees says proper clinical trial data is needed to assess the benefits of cannabis-containing products. She says this move may open the door for quality scientific research and the growth of cannabis for medicinal purposes. We must make sure that we have the evidence to understand if cannabis-containing products work.

— Prof Helen Rees, Chairperson of the Medical Control Council